NCT01212224已完成不适用
Retrospective Safety Study in 12 Months Treatment Nocturia With Minirin Melt in Clinical Practice in Czech Republic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,187
- 试验地点
- 68
- 主要终点
- Verify the safety profile
研究概览
简要总结
This is a confirmation of safety profile for Minirin Melt in clinical practice.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •habitual or psychogenic polydipsia
- •known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
- •moderate and severe renal insufficiency
- •know hyponatremia
- •syndrome of inappropriate ADH secretion
结局指标
主要结局
Verify the safety profile
时间窗: 12 months
次要结局
- Safety aspect of dosage(12 months)
研究者
研究点 (68)
Loading locations...
相似试验
已完成
不适用
A Study of Minirin Melt in 24 Months Treatment in Patients With NocturiaNocturiaNCT01552395Ferring Pharmaceuticals4,136
已完成
不适用
A Study of Minirin Melt in Patients With NocturiaNocturiaNCT01222598Ferring Pharmaceuticals588
终止
不适用
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)Type 2 DiabetesNCT00255645AstraZeneca4,500
已完成
4 期
Long-term Safety of Minocycline in Patients With Gum DiseasePeriodontitisNCT00668746OraPharma35
已完成
3 期
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mgProstatic NeoplasmsNCT02712320Foresee Pharmaceuticals Co., Ltd.30